TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/17/24 19:35 | 6/13/24 | QURE | Uniqure N.V. | Health | Drug | Pharmaceutical Preparations | Meek David D. | P7 | D | S | -11 | 5.12 | 0 | -2 | -10 | 20 | D | ||||||||||||||||
6/20/23 17:25 | 6/16/23 | QURE | Uniqure N.V. | Health | Drug | Pharmaceutical Preparations | Meek David D. | P7 | D | S.d | -43 | 18.85 | 0 | -2 | -9 | 22 | D | ||||||||||||||||
3/1/23 16:09 | 2/27/23 | QURE | Uniqure N.V. | Health | Drug | Pharmaceutical Preparations | Meek David D. | P7 | D | S | -8 | 19.71 | 0 | 0 | -2 | 16 | D | ||||||||||||||||
1/19/23 09:45 | 1/17/23 | MRTX | Mirati Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Meek David D. | CA | DO | CEO | S | -135 | 42.38 | 0 | -3 | -5 | 62 | D | ||||||||||||||
12/21/22 21:20 | 12/21/22 | MRTX | Mirati Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Meek David D. | CA | DO | CEO | S | -187 | 40.41 | 0 | -5 | -7 | 65 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |